Company

Micro Interventional Devices, Inc.

Micro Interventional Devices develops catheter-based technologies for treating structural heart disease.

About

Micro Interventional Devices develops catheter-based technologies for structural heart disease, including the MIA-T system for minimally invasive treatment of tricuspid regurgitation. In March 2019, it raised USD 20 mn in Series D funding led by Oscor, Inc., with participation from Ben Franklin Technology Partners, Life Sciences Greenhouse of Central Pennsylvania, and Originate Ventures. The company is based in Newton, US.

5Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in